Capital Research Global Investors’s Globus Medical GMED Stock Holding History

Capital Research Global Investors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,996,066	Closed	-$148M	–	434
2022 Q4	$148M	Hold	1,996,066	–	–	0.04%	244
2022 Q3	$119M	Buy	1,996,066 +225,751	+13%	+$13.6M	0.04%	248
2022 Q2	$99.4M	Sell	1,770,315 -130,799	-7%	-$8.6M	0.03%	278
2022 Q1	$140M	Hold	1,901,114	–	–	0.03%	277
2021 Q4	$137M	Sell	1,901,114 -57,693	-3%	-$4.19M	0.03%	286
2021 Q3	$150M	Sell	1,958,807 -94,427	-5%	-$7.58M	0.04%	272
2021 Q2	$159M	Hold	2,053,234	–	–	0.04%	266
2021 Q1	$127M	Buy	2,053,234 +136,634	+7%	+$8.65M	0.03%	284
2020 Q4	$125M	Buy	1,916,600 +703,400	+58%	+$40.4M	0.03%	275
2020 Q3	$60.1M	Sell	1,213,200 -229,300	-16%	-$11.8M	0.02%	313
2020 Q2	$68.8M	Buy	1,442,500 +417,250	+41%	+$20.1M	0.02%	301
2020 Q1	$43.6M	Buy	+1,025,250	New	+$50.7M	0.02%	297

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Capital Research Global Investors's GMED Position: Q1 2023 in Review

Capital Research Global Investors sold out of Globus Medical (GMED) in Q1 2023, closing a stake of 1,996,066 shares — an estimated $148M sold.

Capital Research Global Investors first reported a position in GMED in Q1 2020 and held it in 12 quarters. The position peaked at $159M in Q2 2021. 389 funds tracked by Wall St. Rank hold GMED as of Q1 2023.

Capital Research Global Investors reported no remaining Globus Medical position as of Q1 2023 after selling out during the quarter.
Capital Research Global Investors sold 1,996,066 Globus Medical shares in Q1 2023, an estimated $148M.
Capital Research Global Investors first reported a position in Globus Medical in Q1 2020 and held it in 12 quarters.
Capital Research Global Investors's Globus Medical position peaked at $159M in Q2 2021.
389 funds tracked by Wall St. Rank held Globus Medical as of Q1 2023.

Based on Capital Research Global Investors's 13F filing for Q1 2023, filed 15 May 2023.